McKesson (MCK) Competitors $725.07 +18.82 (+2.66%) As of 03:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MCK vs. HOLX, HQY, HSIC, MMSI, AMN, CRL, HUM, ITGR, WST, and CORShould you be buying McKesson stock or one of its competitors? The main competitors of McKesson include Hologic (HOLX), HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Charles River Laboratories International (CRL), Humana (HUM), Integer (ITGR), West Pharmaceutical Services (WST), and Cencora (COR). These companies are all part of the "medical" sector. McKesson vs. Its Competitors Hologic HealthEquity Henry Schein Merit Medical Systems AMN Healthcare Services Charles River Laboratories International Humana Integer West Pharmaceutical Services Cencora McKesson (NYSE:MCK) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk and media sentiment. Is MCK or HOLX more profitable? Hologic has a net margin of 13.79% compared to McKesson's net margin of 0.84%. Hologic's return on equity of 19.69% beat McKesson's return on equity.Company Net Margins Return on Equity Return on Assets McKesson0.84% -196.66% 5.66% Hologic 13.79%19.69%10.82% Which has stronger earnings & valuation, MCK or HOLX? McKesson has higher revenue and earnings than Hologic. Hologic is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMcKesson$359.05B0.25$3.30B$25.0828.92Hologic$4.03B3.65$789.50M$2.4127.47 Does the media refer more to MCK or HOLX? In the previous week, McKesson had 16 more articles in the media than Hologic. MarketBeat recorded 38 mentions for McKesson and 22 mentions for Hologic. McKesson's average media sentiment score of 1.53 beat Hologic's score of 1.40 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 32 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Hologic 17 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, MCK or HOLX? McKesson has a beta of 0.51, indicating that its stock price is 49% less volatile than the S&P 500. Comparatively, Hologic has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Do insiders and institutionals have more ownership in MCK or HOLX? 85.1% of McKesson shares are held by institutional investors. Comparatively, 94.7% of Hologic shares are held by institutional investors. 0.1% of McKesson shares are held by company insiders. Comparatively, 1.9% of Hologic shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts rate MCK or HOLX? McKesson presently has a consensus price target of $725.10, suggesting a potential downside of 0.04%. Hologic has a consensus price target of $78.00, suggesting a potential upside of 17.81%. Given Hologic's higher probable upside, analysts clearly believe Hologic is more favorable than McKesson.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score McKesson 0 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.85Hologic 0 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.59 SummaryMcKesson and Hologic tied by winning 8 of the 16 factors compared between the two stocks. Get McKesson News Delivered to You Automatically Sign up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MCK vs. The Competition Export to ExcelMetricMcKessonMED/DENTAL IndustryMedical SectorNYSE ExchangeMarket Cap$90.22B$16.34B$5.83B$21.63BDividend Yield0.46%1.52%5.25%3.51%P/E Ratio28.9218.8375.8829.85Price / Sales0.252.24533.3551.48Price / Cash18.1613.3837.4224.46Price / Book-53.663.4411.904.61Net Income$3.30B$472.94M$3.29B$999.91M7 Day Performance4.98%-1.13%2.01%1.61%1 Month Performance7.67%-0.22%8.94%7.03%1 Year Performance42.11%9.02%66.35%17.55% McKesson Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MCKMcKesson4.5089 of 5 stars$725.07+2.7%$725.10+0.0%+39.6%$90.14B$359.05B28.9045,000News CoveragePositive NewsHOLXHologic4.9069 of 5 stars$67.12+0.8%$78.00+16.2%-20.1%$14.93B$4.03B27.857,063News CoveragePositive NewsHQYHealthEquity4.3382 of 5 stars$89.33+1.2%$117.82+31.9%+22.5%$7.72B$1.24B65.203,120Positive NewsAnalyst RevisionHSICHenry Schein3.7069 of 5 stars$69.58+0.8%$76.67+10.2%-0.2%$8.44B$12.67B22.4525,000Positive NewsMMSIMerit Medical Systems4.6616 of 5 stars$90.54+0.5%$107.00+18.2%-8.2%$5.36B$1.36B45.967,400Positive NewsAMNAMN Healthcare Services4.4781 of 5 stars$20.77+3.6%$28.25+36.0%-56.7%$795.98M$2.98B-2.672,968Trending NewsAnalyst ForecastShort Interest ↓Analyst RevisionCRLCharles River Laboratories International4.5375 of 5 stars$163.29+0.0%$175.69+7.6%-19.3%$8.04B$4.03B-122.7720,100Positive NewsAnalyst UpgradeShort Interest ↑HUMHumana4.2939 of 5 stars$303.90+2.0%$283.29-6.8%-21.1%$36.55B$117.76B23.3265,680Positive NewsITGRInteger3.8495 of 5 stars$107.58+0.2%$140.25+30.4%-16.8%$3.77B$1.72B47.3911,000Positive NewsWSTWest Pharmaceutical Services4.9731 of 5 stars$247.18+0.7%$320.71+29.7%-16.4%$17.77B$2.96B37.0010,600Positive NewsCORCencora4.7626 of 5 stars$291.51+0.6%$311.25+6.8%+24.8%$56.52B$293.96B29.9946,000News CoveragePositive News Related Companies and Tools Related Companies HOLX Competitors HQY Competitors HSIC Competitors MMSI Competitors AMN Competitors CRL Competitors HUM Competitors ITGR Competitors WST Competitors COR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MCK) was last updated on 9/11/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding McKesson Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share McKesson With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
